Biotome develops antibody tests using next generation technology and precision immunology to address the problems of traditional serology tests.
Our antibody tests surpass current antibody screening with enhanced precision and more detailed disease information.
We use an efficient, scalable process of discovering precision markers for diagnosis, applicable to any disease that triggers an immune response.
The patentable peptide markers are fundamental to our commercialization process. IP protection carves out space for our precision diagnostics in a market dominated by lower-accuracy, non-proprietary tests from huge corporations.
Biotome also offers cutting-edge expertise in marker identification, patenting, and precision immunology data analytics to research companies and organizations.
Company Details
- Employees
- 10
- Founded
- 2017
- Address
- 6 Verdun St, Perth,western Australia 6009,australia
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.biotome.com.au
- Keywords
- Immunology, Diagnostics, Biosensors, Cancer, Infectious Disease, Virus, Epitope, Serology, Next Generation Serology, Precision Immunology, Point-of-Care Tests, Antibody Test, Stomach Cancer, Helicobacter.
- HQ
- Perth, Western Australia
Biotome Pty Ltd Questions
Biotome Pty Ltd's website is http://www.biotome.com.au
Biotome Pty Ltd's LinkedIn profile is https://au.linkedin.com/company/biotome-pty-ltd
Biotome Pty Ltd has
10 employees.
View email and phone details for 10
employees at Biotome Pty Ltd.
Biotome Pty Ltd's industry is
Biotechnology Research
Biotome Pty Ltd's top competitors are
Inspiring Holdings Pty Ltd,
Linear Clinical Research,
Syngenis,
Veintech,
Reliis,
Navier Medical,
Oqea,
Lixa,
Corametix,
The Mullings Group.
Biotome Pty Ltd's categories are Biotechnology Research
Biotome Pty Ltd's founding year is 2017
